KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Halozyme Therapeutics (HALO) over the last 16 years, with Q4 2024 value amounting to $1.4 million.

  • Halozyme Therapeutics' Treasury Shares rose 2277.12% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 2277.12%. This contributed to the annual value of $1.4 million for FY2024, which is 2277.12% up from last year.
  • According to the latest figures from Q4 2024, Halozyme Therapeutics' Treasury Shares is $1.4 million, which was up 2277.12% from $19.1 million recorded in Q2 2024.
  • Halozyme Therapeutics' 5-year Treasury Shares high stood at $19.1 million for Q2 2024, and its period low was $88307.0 during Q2 2020.
  • In the last 5 years, Halozyme Therapeutics' Treasury Shares had a median value of $3.9 million in 2021 and averaged $4.8 million.
  • Per our database at Business Quant, Halozyme Therapeutics' Treasury Shares soared by 107493.18% in 2021 and then plummeted by 7468.14% in 2023.
  • Quarter analysis of 5 years shows Halozyme Therapeutics' Treasury Shares stood at $6.5 million in 2020, then plummeted by 40.0% to $3.9 million in 2021, then rose by 15.38% to $4.5 million in 2022, then tumbled by 74.68% to $1.1 million in 2023, then grew by 22.77% to $1.4 million in 2024.
  • Its Treasury Shares was $1.4 million in Q4 2024, compared to $19.1 million in Q2 2024 and $12.6 million in Q1 2024.